AbCellera Biologics (ABCL) Goodwill & Intangibles (2020 - 2026)

AbCellera Biologics has reported Goodwill & Intangibles for 7 years, with the latest figure at $85.3 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles fell 4.19% year-over-year to $85.3 million; the trailing twelve-month figure through Mar 2026 stood at $85.3 million (down 4.19% YoY), and the FY2025 full-year result was $86.2 million, down 4.14% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $85.3 million, down from $86.2 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $210.8 million in Q3 2022, with the low at $85.3 million in Q1 2026.
• Historically, Goodwill & Intangibles has averaged $141.6 million across 5 years, with a median of $166.5 million in 2024.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles surged 132.76% — and 2025, when it slumped 46.56%.
• AbCellera Biologics' Goodwill & Intangibles stood at $179.3 million in 2022, then retreated by 6.18% to $168.2 million in 2023, then slumped by 46.55% to $89.9 million in 2024, then fell by 4.14% to $86.2 million in 2025, then decreased by 1.07% to $85.3 million in 2026.
• The last three Goodwill & Intangibles figures came in at $85.3 million (Q1 2026), $86.2 million (Q4 2025), and $87.1 million (Q3 2025), per Business Quant data.